Differential effects of sympathetic nervous system and hypothalamic-pituitary-adrenal axis on systemic immune cells after severe experimental stroke

Brain, Behavior, and Immunity

Volumn 41, Issue 1, 2014, Pages 200-209

  Mracsko, Eva ^a   Liesz, Arthur ^a,b,c   Karcher, Simone ^a   Zorn, Markus ^a   Bari, Ferenc ^d   Veltkamp, Roland ^a,e  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Germany 3 Munich Cluster for Systems Neurology   (Germany)

^d UNIVERSITY OF SZEGED   (Hungary)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Catecholamines; Glucocorticoids; Lymphocytes; Stroke induced immunosuppression

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ADRENALIN; BETA 2 ADRENERGIC RECEPTOR; CORTICOSTERONE; CORTICOTROPIN; CORTISONE; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; METADRENALIN; MIFEPRISTONE; PREDNISOLONE; STRESS HORMONE; PROPANOLAMINE DERIVATIVE;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL DEATH; CELL POPULATION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; EX VIVO STUDY; EXPERIMENTAL STROKE; FLOW CYTOMETRY; HEMISPHERE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; LYMPHOCYTOPENIA; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; SPLEEN; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CEREBRAL ARTERY DISEASE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; FEEDBACK SYSTEM; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOLOGY; IMMUNOMODULATION; LYMPHOPENIA; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CORTICOSTERONE; CORTISONE; EPINEPHRINE; FEEDBACK, PHYSIOLOGICAL; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERFERON-GAMMA; LEUKOCYTES; LYMPHOPENIA; MALE; METANEPHRINE; MICE; MICE, INBRED C57BL; MIFEPRISTONE; NEUROIMMUNOMODULATION; PITUITARY-ADRENAL SYSTEM; PREDNISOLONE; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, GLUCOCORTICOID; SYMPATHETIC NERVOUS SYSTEM;

EID: 84924076763     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.05.015     Document Type: Article

References (49)

1. Chamorro A., Amaro S., Vargas M., Obach V., Cervera A., Torres F., Planas A.M. Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. J. Neurol. Neurosurg. Psychiatry 2006, 77:1279-1281.
2. Chamorro A., Amaro S., Vargas M., Obach V., Cervera A., Gomez-Choco M., Torres F., Planas A.M. Catecholamines, infection, and death in acute ischemic stroke. J. Neurol. Sci. 2007, 252:29-35.
3. Chamorro A., Urra X., Planas A.M. Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 2007, 38:1097-1103.
4. Czlonkowska A., Cyrta B., Korlak J. Immunological observations on patients with acute cerebral vascular disease. J. Neurol. Sci. 1979, 43:455-464.
5. Dangel V., Giray J., Ratge D., Wisser H. Regulation of beta-adrenoceptor density and mRNA levels in the rat heart cell-line H9c2. Biochem. J. 1996, 317(Pt 3):925-931.
6. Dziedzic T., Slowik A., Pera J., Szczudlik A. Beta-blockers reduce the risk of early death in ischemic stroke. J. Neurol. Sci. 2007, 252:53-56.
7. Eisenhofer G., Rundquist B., Aneman A., Friberg P., Dakak N., Kopin I.J., Jacobs M.C., Lenders J.W. Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. J. Clin. Endocrinol. Metab. 1995, 80:3009-3017.
8. Eisenhofer G., Keiser H., Friberg P., Mezey E., Huynh T.T., Hiremagalur B., Ellingson T., Duddempudi S., Eijsbouts A., Lenders J.W. Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J. Clin. Endocrinol. Metab. 1998, 83:2175-2185.
9. Fassbender K., Schmidt R., Mossner R., Daffertshofer M., Hennerici M. Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke. Relation to acute confusional state, extent of brain damage, and clinical outcome. Stroke 1994, 25:1105-1108.
10. Feibel J.H., Hardy P.M., Campbell R.G., Goldstein M.N., Joynt R.J. Prognostic value of the stress response following stroke. JAMA 1977, 238:1374-1376.
11. Friedman G., Jankowski S., Marchant A., Goldman M., Kahn R.J., Vincent J.L. Blood interleukin 10 levels parallel the severity of septic shock. J. Crit. Care 1997, 12:183-187.
12. Fuchs B.A., Albright J.W., Albright J.F. Beta-adrenergic receptors on murine lymphocytes: density varies with cell maturity and lymphocyte subtype and is decreased after antigen administration. Cell. Immunol. 1988, 114:231-245.
13. Haeusler K.G., Schmidt W.U., Fohring F., Meisel C., Helms T., Jungehulsing G.J., Nolte C.H., Schmolke K., Wegner B., Meisel A., Dirnagl U., Villringer A., Volk H.D. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc. Dis. 2008, 25:50-58.
14. Herve J., Dubreil L., Tardif V., Terme M., Pogu S., Anegon I., Rozec B., Gauthier C., Bach J.M., Blancou P. Beta2-Adrenoreceptor agonist inhibits antigen cross-presentation by dendritic cells. J. Immunol. 2013, 190:3163-3171.
15. Heuschmann P.U., Kolominsky-Rabas P.L., Misselwitz B., Hermanek P., Leffmann C., Janzen R.W., Rother J., Buecker-Nott H.J., Berger K. Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch. Intern. Med. 2004, 164:1761-1768.
16. Hug A., Dalpke A., Wieczorek N., Giese T., Lorenz A., Auffarth G., Liesz A., Veltkamp R. Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke 2009, 40:3226-3232.
17. Iadecola C., Anrather J. The immunology of stroke: from mechanisms to translation. Nat. Med. 2011, 17:796-808.
18. Ichikawa Y., Yoshida K., Kawagoe M., Saito E., Abe Y., Arikawa K., Homma M. Altered equilibrium between cortisol and cortisone in plasma in thyroid dysfunction and inflammatory diseases. Metabolism 1977, 26:989-997.
19. Johansson A., Olsson T., Carlberg B., Karlsson K., Fagerlund M. Hypercortisolism after stroke - partly cytokine-mediated?. J. Neurol. Sci. 1997, 147:43-47.
20. Klehmet J., Harms H., Richter M., Prass K., Volk H.D., Dirnagl U., Meisel A., Meisel C. Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 2009, 158:1184-1193.
21. Kohm A.P., Sanders V.M. Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol. Rev. 2001, 53:487-525.
22. Lahteenmaki P., Heikinheimo O., Croxatto H., Spitz I., Shoupe D., Birgerson L., Luukkainen T. Pharmacokinetics and metabolism of RU 486. J. Steroid Biochem. 1987, 27:859-863.
23. Liesz A., Hagmann S., Zschoche C., Adamek J., Zhou W., Sun L., Hug A., Zorn M., Dalpke A., Nawroth P., Veltkamp R. The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke 2009, 40:2849-2858.
24. Liesz A., Ruger H., Purrucker J., Zorn M., Dalpke A., Mohlenbruch M., Englert S., Nawroth P.P., Veltkamp R. Stress mediators and immune dysfunction in patients with acute cerebrovascular diseases. PLoS ONE 2013, 8:e74839.
25. Macrez R., Ali C., Toutirais O., Le Mauff B., Defer G., Dirnagl U., Vivien D. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 2011, 10:471-480.
26. Mak J.C., Nishikawa M., Shirasaki H., Miyayasu K., Barnes P.J. Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo. J. Clin. Invest. 1995, 96:99-106.
27. Marra S., Burnett M., Hoffman-Goetz L. Intravenous catecholamine administration affects mouse intestinal lymphocyte number and apoptosis. J. Neuroimmunol. 2005, 158:76-85.
28. Meisel C., Meisel A. Suppressing immunosuppression after stroke. N. Engl. J. Med. 2011, 365:2134-2136.
29. Meisel C., Schwab J.M., Prass K., Meisel A., Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat. Rev. Neurosci. 2005, 6:775-786.
30. Minnerup J., Wersching H., Brokinkel B., Dziewas R., Heuschmann P.U., Nabavi D.G., Ringelstein E.B., Schabitz W.R., Ritter M.A. The impact of lesion location and lesion size on poststroke infection frequency. J. Neurol. Neurosurg. Psychiatry 2010, 81:198-202.
31. Molinoff P.B., Aarons R.D. Effects of drugs on beta-adrenergic receptors on human lymphocytes. J. Cardiovasc. Pharmacol. 1983, 5(Suppl 1):S63-S67.
32. Offner H., Subramanian S., Parker S.M., Wang C., Afentoulis M.E., Lewis A., Vandenbark A.A., Hurn P.D. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J. Immunol. 2006, 176:6523-6531.
33. Olsson T. Urinary free cortisol excretion shortly after ischaemic stroke. J. Intern. Med. 1990, 228:177-181.
34. Olsson T., Marklund N., Gustafson Y., Nasman B. Abnormalities at different levels of the hypothalamic-pituitary-adrenocortical axis early after stroke. Stroke 1992, 23:1573-1576.
35. Prass K., Meisel C., Hoflich C., Braun J., Halle E., Wolf T., Ruscher K., Victorov I.V., Priller J., Dirnagl U., Volk H.D., Meisel A. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J. Exp. Med. 2003, 198:725-736.
36. Prass K., Braun J.S., Dirnagl U., Meisel C., Meisel A. Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 2006, 37:2607-2612.
37. Pratt W.B., Gehring U., Toft D.O. Molecular chaperoning of steroid hormone receptors. EXS 1996, 77:79-95.
38. Radojcic T., Baird S., Darko D., Smith D., Bulloch K. Changes in beta-adrenergic receptor distribution on immunocytes during differentiation: an analysis of T cells and macrophages. J. Neurosci. Res. 1991, 30:328-335.
39. Ramer-Quinn D.S., Baker R.A., Sanders V.M. Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. J. Immunol. 1997, 159:4857-4867.
40. Sander D., Winbeck K., Klingelhofer J., Etgen T., Conrad B. Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke. Neurology 2001, 57:833-838.
41. Schoenborn J.R., Wilson C.B. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 2007, 96:41-101.
42. Schwarz S., Schwab S., Klinga K., Maser-Gluth C., Bettendorf M. Neuroendocrine changes in patients with acute space occupying ischaemic stroke. J. Neurol. Neurosurg. Psychiatry 2003, 74:725-727.
43. Seleznev Iu M., Martynov A.V. Permissive effect of glucocorticoids in catecholamine action in the heart: possible mechanism. J. Mol. Cell. Cardiol. 1982, 14(Suppl. 3):49-58.
44. Tamura A., Graham D.I., McCulloch J., Teasdale G.M. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1981, 1:53-60.
45. Tuckermann J.P., Kleiman A., McPherson K.G., Reichardt H.M. Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit. Rev. Clin. Lab. Sci. 2005, 42:71-104.
46. Udelsman R., Goldstein D.S., Loriaux D.L., Chrousos G.P. Catecholamine-glucocorticoid interactions during surgical stress. J. Surg. Res. 1987, 43:539-545.
47. Woiciechowsky C., Schoning B., Daberkow N., Asche K., Stoltenburg G., Lanksch W.R., Volk H.D. Brain-IL-1beta induces local inflammation but systemic anti-inflammatory response through stimulation of both hypothalamic-pituitary-adrenal axis and sympathetic nervous system. Brain Res. 1999, 816:563-571.
48. Woiciechowsky C., Schoning B., Lanksch W.R., Volk H.D., Docke W.D. Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. J. Mol. Med. (Berl) 1999, 77:769-780.
49. Wong C.H., Jenne C.N., Lee W.Y., Leger C., Kubes P. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 2011, 334:101-105.